1)Hamano H, Kawa S, Horiuchi A et al:High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732-738, 2001
2)Goto H, Takahira M, Azumi A et al:Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 59:1-7, 2015
3)日本眼科アレルギー学会診療ガイドライン作成委員会:アレルギー性結膜疾患診療ガイドライン(第3版).日眼会誌125:741-785,2021
4)Umehara H, Okazaki K, Masaki Y et al:Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011. Mod Rheumatol 22:21-30, 2012
5)Sogabe Y, Ohsihma K, Azumi A et al:Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252:531-538, 2014
6)Goto H, Ueda S, Nemoto R at al:Clinical features and symptoms of IgG4-related ophthalmic disease:a multicenter study. Jpn J Ophthalmol 65:651-656, 2021
7)Fukushima A, Maruoka S, Tabuchi H:A case of IgG4-related conjunctival tumor with severe systemic allergy treated with antibodies against cytokine receptors. Am J Ophthalmol Case Rep 26:101469, 2022
8)正木康史・藤本信乃・河南(岩男)悠・他:IgG4関連疾患の診断と治療.金沢医科大学雑誌41:67-72,2016
9)Kubota T, Katayama M, Nishimura R et al:Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease. Br J Ophthalmol 104:345-349, 2020